Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Haitao Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4168-4053; OpenAlex author ID A5017383224. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 14

  1. Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity. Co-author DOI 10.1016/j.fmre.2025.12.010↗
  2. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities. Last author DOI 10.1016/j.canlet.2024.216859↗
  3. Activated Stellate Cell Paracrine HGF Exacerbated Pancreatic Cancer Cell Ferroptosis Resistance. Co-author DOI 10.1155/2022/2985249↗
  4. O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Last author DOI 10.7150/ijbs.71520↗
  5. Stearoyl-CoA Desaturase 1 Potentiates Hypoxic plus Nutrient-Deprived Pancreatic Cancer Cell Ferroptosis Resistance. Last author DOI 10.1155/2021/6629804↗
  6. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness. Last author DOI 10.1038/s41419-019-1956-8↗
  7. Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells. Last author DOI 10.2147/dddt.s199459↗
  8. Retraction notice to "CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic… First author DOI 10.1016/j.acthis.2018.03.005↗
  9. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Co-author DOI 10.1371/journal.pone.0158529↗
  10. [CCL21 promotes the metastasis of human pancreatic cancer Panc-1 cells via epithelial- mesenchymal transition]. Co-author PMID 25575049↗
  11. The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-lik… First author DOI 10.1155/2014/760303↗
  12. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hy… Co-author DOI 10.3892/or.2014.3298↗
  13. CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. First author DOI 10.1016/j.acthis.2012.09.007↗
  14. Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like ce… Co-author DOI 10.1186/1475-2867-13-119↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanfang Liu · 9 shared papers, 2013–2022 · strength 0.66
  2. Aihua Gong · 5 shared papers, 2019–2022 · strength 0.61
  3. Xin Wang · 2 shared papers, 2022–2026 · strength 0.42
  4. Dongqing Wang · 2 shared papers, 2014–2026 · strength 0.32
  5. Dongqing Wang · 6 shared papers, 2013–2018 · strength 0.31
  6. Zhaoliang Su · 6 shared papers, 2013–2018 · strength 0.30
  7. Qin Qin · 1 shared paper, 2024 · strength 0.28
  8. Hsiang‐i Tsai · 1 shared paper, 2024 · strength 0.28
  9. Dongqing Wang · 2 shared papers, 2021–2022 · strength 0.28
  10. Xiang Liao · 1 shared paper, 2026 · strength 0.27
  11. Wenjin Xu · 1 shared paper, 2026 · strength 0.27
  12. Zhengyang Zhang · 2 shared papers, 2019–2021 · strength 0.23
  13. Lirong Zhang · 3 shared papers, 2014–2019 · strength 0.18
  14. Qiwei Wu · 1 shared paper, 2022 · strength 0.15
  15. Mengqi Liu · 1 shared paper, 2022 · strength 0.15
  16. Jie Gao · 1 shared paper, 2021 · strength 0.13
  17. Kang Wang · 1 shared paper, 2019 · strength 0.10
  18. Qing Liu · 2 shared papers, 2014–2015 · strength 0.09
  19. Hongbo Chen · 1 shared paper, 2019 · strength 0.09
  20. Xin Fan · 1 shared paper, 2019 · strength 0.09
  21. Genbao Shao · 2 shared papers, 2013–2014 · strength 0.08
  22. Jianxin Zhang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.